Pivhydrazine

DB09252ApprovedWithdrawnSmall molecule

Pivhydrazine, also known as pivazide, is a member of the hydrazine family with irreversible and non-selective inhibitory activity against monoamine oxidases. In 1960, it was widely used as an antidepressant...

Primary indication: For the treatment of depression.Curator reviewed
Formula / weight: C₁₂H₁₈N₂O · 206.289 g/mol (avg)
Also known as: Pivalylbenzhydrazine · Pivazide

Resolves to

Compound

UNIITK1T520ASGCAS306-19-4ChEMBLCHEMBL2106941ChEBI134868PubChem9375

Structure

InChIKeyFWWDFDMCZLOXQI-UHFFFAOYSA-NSMILES[H]N(CC1=CC=CC=C1)N([H])C(=O)C(C)(C)C

What you can answer from here — as of April 02, 2025

1,331Drug interactionsStructured to mechanism, not free text

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Pivhydrazine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account